NCT04458909 2025-10-03Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal CancerNational Cancer Institute (NCI)Phase 3 Terminated15 enrolled 17 charts